Dr.med.univ. Moritz Ferch
Department of Medicine III (Division of Endocrinology and Metabolism)
Position: PHD Student
ORCID: 0000-0001-7786-8156
Keywords
Diabetes Mellitus; Dyslipidemias; Hypercholesterolemia
Research interests
Strategies for improving cardiometabolic risk stratification, diagnostic yield, and therapeutic care for patients with dyslipidemia.
Techniques, methods & infrastructure
Clinical Studies
Selected publications
- Ferch, M. et al. (2024) ‘PCSK9 inhibitors in real life—Cardiometabolic risk management in dyslipidemic patients in Vienna’, Wiener klinische Wochenschrift [Preprint]. Available at: https://doi.org/10.1007/s00508-024-02402-9.
- Fellinger, P. et al. (2022) ‘HbA1c and Glucose Management Indicator Discordance Associated with Obesity and Type 2 Diabetes in Intermittent Scanning Glucose Monitoring System’, Biosensors, 12(5), p. 288. Available at: https://doi.org/10.3390/bios12050288.